CDC Backs FDA’s Recommendation to Shorten Booster Wait Time by One Month

This morning, the CDC recommended the FDA's decision to shorten the interval between an initial series of the Pfizer vaccine and a booster shot from 6 months to 5 months.

After the FDA recommended shortening the booster wait time, the CDC is backing the decision as well. This morning, the CDC recommended the FDA’s decision to shorten the interval between an initial series of the Pfizer vaccine and a booster shot from 6 months to 5 months. The FDA also recommended boosters for children ages 12 to 15. The CDC plans to meet with their advisory board tomorrow to discuss expanding the boosters eligibility to children. The FDA updated it’s recommendation after review of data from Israel showed that there were ‘no new safety concerns’ in expanding boosters to adolescents or shortening the time frame between vaccines and boosters. Currently about half of the population ages 12 to 15 is fully vaccinated according to data from the CDC and about 5 million have been fully vaccinated for more than five months and are now eligible to receive a booster.